Suchergebnisse - "Hui, David S"

PubPharm (11)

1

Cross-neutralizing antibody against emerging Omicron subvariants of SARS-CoV-2 in infection-naïve individuals with homologous BNT162b2 or BNT162b2(WT + BA.4/5) bivalent booster vaccination

enthalten in: Virology journal | 2024

von Cheng, S. | Mok, C. | Li, J. | +16

2

Serological assays for differentiating natural COVID-19 infection from vaccine induced immunity

enthalten in: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology | 2024

von Cheng, S. | Lau, J. | Tsang, L. | +17

3

Baseline gut microbiota and metabolome predict durable immunogenicity to SARS-CoV-2 vaccines

enthalten in: Signal transduction and targeted therapy | 2023

von Peng, Y. | Zhang, L. | Mok, C. | +19

4

Effectiveness of mRNA and inactivated COVID-19 vaccines : A test-negative study in an infection-naïve Hong Kong population

enthalten in: The Journal of infection | 2023

von Ng, R. | Sze, R. | Chong, K. | +11

CommentIn: J Infect. 2023 Sep;87(3):e61-e62. - PMID 37414158

5

Omicron BA.1-specific T-cell responses in adults vaccinated with CoronaVac or BNT162b2 in Hong Kong : an observational cohort study

enthalten in: The Lancet. Microbe | 2023

von Mok, C. | Chen, C. | Zhao, S. | +12

6

Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population

enthalten in: Nature medicine | 2023

von Lau, J. | Cheng, S. | Leung, K. | +17

ErratumIn: Nat Med. 2023 Oct 24;:. - PMID 37875568

7

Priming conditions shape breadth of neutralizing antibody responses to sarbecoviruses

enthalten in: Nature communications | 2022

von Jia, J. | Tan, C. | Cheng, S. | +12

8

Reply to Mungmunpuntipantip and Wiwanitkit : CoronaVac or BNT162b2 Vaccine as a Third Dose

enthalten in: American journal of respiratory and critical care medicine | 2022

von Mok, C. | Hui, D. | Peiris, M.

CommentOn: Am J Respir Crit Care Med. 2022 Apr 1;205(7):844-847. - PMID 35015969

9

Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID-19 vaccines in Hong Kong

enthalten in: Respirology (Carlton, Vic.) | 2022

von Mok, C. | Cohen, C. | Cheng, S. | +16

CommentIn: Respirology. 2022 Apr;27(4):260-261. - PMID 35229416

10

A Randomized Clinical Trial Using CoronaVac or BNT162b2 Vaccine as a Third Dose in Adults Vaccinated with Two Doses of CoronaVac

enthalten in: American journal of respiratory and critical care medicine | 2022

von Mok, C. | Chen, C. | Yiu, K. | +7

CommentIn: Am J Respir Crit Care Med. 2022 Aug 1;206(3):361-362. - PMID 35561327